Kaminski HJ - Search Results

1

Importance and hurdles to drug discovery for neurological disease.

Berger JR, Choi D, Kaminski HJ, Gordon MF, Hurko O, D'Cruz O, Pleasure SJ, Feldman EL. Berger JR, et al. Among authors: kaminski hj. Ann Neurol. 2013 Sep;74(3):441-6. doi: 10.1002/ana.23997. Ann Neurol. 2013. PMID: 25813523 Free article. Review.

2

Evidence report: the medical treatment of ocular myasthenia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.

Benatar M, Kaminski HJ; Quality Standards Subcommittee of the American Academy of Neurology. Benatar M, et al. Among authors: kaminski hj. Neurology. 2007 Jun 12;68(24):2144-9. doi: 10.1212/01.wnl.0000263481.14289.90. Epub 2007 Apr 25. Neurology. 2007. PMID: 17460154 Review.

3

Novel complement inhibitor limits severity of experimentally myasthenia gravis.

Soltys J, Kusner LL, Young A, Richmonds C, Hatala D, Gong B, Shanmugavel V, Kaminski HJ. Soltys J, et al. Among authors: kaminski hj. Ann Neurol. 2009 Jan;65(1):67-75. doi: 10.1002/ana.21536. Ann Neurol. 2009. PMID: 19194881 Free PMC article.

4

Shortage of generic neurologic therapeutics: An escalating threat to patient care.

Omorodion JO, Algahtani RM, Zocchi MS, Fox ER, Pines JM, Kaminski HJ. Omorodion JO, et al. Among authors: kaminski hj. Neurology. 2017 Dec 12;89(24):2431-2437. doi: 10.1212/WNL.0000000000004737. Epub 2017 Nov 15. Neurology. 2017. PMID: 29142086

5

Neuromuscular junction as Achilles' heel: yet another autoantibody?

Drachman DB, Kaminski HJ. Drachman DB, et al. Among authors: kaminski hj. Neurology. 2014 Jun 3;82(22):1942-3. doi: 10.1212/WNL.0000000000000486. Epub 2014 May 2. Neurology. 2014. PMID: 24793186 No abstract available.

6

The third leg of neurology training: the business of medicine.

Kaminski HJ, Busis N. Kaminski HJ, et al. Neurology. 2014 Nov 11;83(20):1778-9. doi: 10.1212/WNL.0000000000000990. Epub 2014 Oct 8. Neurology. 2014. PMID: 25298307 No abstract available.

7

Rare disease levels of evidence: Time for a new bar?

Bril V, Kaminski HJ. Bril V, et al. Among authors: kaminski hj. Neurology. 2017 Sep 5;89(10):988-989. doi: 10.1212/WNL.0000000000004343. Epub 2017 Aug 11. Neurology. 2017. PMID: 28801339 No abstract available.

8

Ocular myasthenia revisited: insights from pseudo-internuclear ophthalmoplegia.

Khanna S, Liao K, Kaminski HJ, Tomsak RL, Joshi A, Leigh RJ. Khanna S, et al. Among authors: kaminski hj. J Neurol. 2007 Nov;254(11):1569-74. doi: 10.1007/s00415-007-0591-y. Epub 2007 Aug 27. J Neurol. 2007. PMID: 17713827

9

How clinical trials of myasthenia gravis can inform pre-clinical drug development.

Rostedt Punga A, Kaminski HJ, Richman DP, Benatar M. Rostedt Punga A, et al. Among authors: kaminski hj. Exp Neurol. 2015 Aug;270:78-81. doi: 10.1016/j.expneurol.2014.12.022. Epub 2015 Jan 13. Exp Neurol. 2015. PMID: 25592627 Free PMC article.

10

Two steps forward, one step back: mycophenolate mofetil treatment for myasthenia gravis in the United States.

Burns TM, Sanders DB, Kaminski HJ, Wolfe GI, Narayanaswami P, Venitz J. Burns TM, et al. Among authors: kaminski hj. Muscle Nerve. 2015 May;51(5):635-7. doi: 10.1002/mus.24608. Epub 2015 Mar 31. Muscle Nerve. 2015. PMID: 25704880 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

191 results

Search Page

Filters